{
    "xml": "<topic id=\"PHP4622\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/desmopressin\" basename=\"desmopressin\" title=\"DESMOPRESSIN\">\n<title>DESMOPRESSIN</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_795\" namespace=\"/interactions/list-of-drug-interactions/desmopressin\">Desmopressin</xref>\n</p>\n<data name=\"vtmid\">73454001</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_911541864\" title=\"Vasopressin and analogues\">Vasopressin and analogues</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP64508\" outputclass=\"drugAction\" rev=\"1.8\" parent=\"/drugs/desmopressin\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Desmopressin is an analogue of vasopressin.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64351\" outputclass=\"indicationsAndDose\" rev=\"1.64\" parent=\"/drugs/desmopressin\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Diabetes insipidus, treatment</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;1 year</p>\n<p>Initially 10&#8239;micrograms 2&#8211;3 times a day, adjusted according to response; usual dose 30&#8211;150&#8239;micrograms daily.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;11 years</p>\n<p>Initially 50&#8239;micrograms 2&#8211;3 times a day, adjusted according to response; usual dose 100&#8211;800&#8239;micrograms daily.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>Initially 100&#8239;micrograms 2&#8211;3 times a day, adjusted according to response; usual dose 0.2&#8211;1.2&#8239;mg daily.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 100&#8239;micrograms 3 times a day; maintenance 100&#8211;200&#8239;micrograms 3 times a day; usual dose 0.2&#8211;1.2&#8239;mg daily.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By sublingual administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;17 years</p>\n<p>Initially 60&#8239;micrograms 3 times a day, adjusted according to response; usual dose 40&#8211;240&#8239;micrograms 3 times a day.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 60&#8239;micrograms 3 times a day, adjusted according to response; usual dose 40&#8211;240&#8239;micrograms 3 times a day.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intranasal administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;1 year</p>\n<p>Initially 2.5&#8211;5&#8239;micrograms 1&#8211;2 times a day, adjusted according to response.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;11 years</p>\n<p>Initially 5&#8211;20&#8239;micrograms 1&#8211;2 times a day, adjusted according to response.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>Initially 10&#8211;20&#8239;micrograms 1&#8211;2 times a day, adjusted according to response.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10&#8211;40&#8239;micrograms daily in 1&#8211;2 divided doses.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection or by intravenous injection or by intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8211;4&#8239;micrograms daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Primary nocturnal enuresis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 5&#8211;17 years</p>\n<p>200&#8239;micrograms once daily, only increased to 400&#8239;micrograms if lower dose not effective; withdraw for at least 1 week for reassessment after 3 months, dose to be taken at bedtime, limit fluid intake from 1 hour before to 8 hours after administration.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult 18&#8211;65 years</p>\n<p>200&#8239;micrograms once daily, only increased to 400&#8239;micrograms if lower dose not effective; withdraw for at least 1 week for reassessment after 3 months, dose to be taken at bedtime, limit fluid intake from 1 hour before to 8 hours after administration.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By sublingual administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 5&#8211;17 years</p>\n<p>120&#8239;micrograms once daily, increased if necessary to 240&#8239;micrograms once daily, dose to be taken at bedtime, limit fluid intake from 1 hour before to 8 hours after administration, dose to be increased only if lower dose not effective, reassess after 3 months by withdrawing treatment for at least 1 week.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult 18&#8211;65 years</p>\n<p>120&#8239;micrograms once daily, increased if necessary to 240&#8239;micrograms once daily, dose to be taken at bedtime, limit fluid intake from 1 hour before to 8 hours after administration, dose to be increased only if lower dose not effective, reassess after 3 months by withdrawing treatment for at least 1 week.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Postoperative polyuria or polydipsia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Dose to be adjusted according to urine osmolality.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Polyuria or polydipsia after hypophysectomy</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By sublingual administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Dose to be adjusted according to urine osmolality.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Diabetes insipidus, diagnosis (water deprivation test)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intranasal administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>20&#8239;micrograms, limit fluid intake to 500&#8239;mL from 1 hour before to 8 hours after administration.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection or by subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2&#8239;micrograms for 1 dose, limit fluid intake to 500&#8239;mL from 1 hour before to 8 hours after administration.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Nocturia associated with multiple sclerosis (when other treatments have failed)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intranasal administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult 18&#8211;65 years</p>\n<p>10&#8211;20&#8239;micrograms once daily, to be taken at bedtime, dose not to be repeated within 24 hours, limit fluid intake from 1 hour before to 8 hours after administration.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Renal function testing</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intranasal administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>40&#8239;micrograms, empty bladder at time of administration and limit fluid intake to 500&#8239;mL from 1 hour before until 8 hours after administration to avoid fluid overload.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection or by intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2&#8239;micrograms, empty bladder at time of administration and restrict fluid intake to 500&#8239;mL from 1 hour before until 8 hours after administration to avoid fluid overload.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Mild to moderate haemophilia and von Willebrand&#8217;s disease</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intranasal administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>300&#8239;micrograms every 12&#8239;hours if required, one 150&#8239;microgram spray into each nostril, 30 minutes before surgery or when bleeding, dose may alternatively be repeated at intervals of at least 3&#8239;days, if self-administered.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion or by subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>300&#8239;nanograms/kg for 1 dose, to be administered immediately before surgery or after trauma; may be repeated at intervals of 12 hours if no tachycardia.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Fibrinolytic response testing</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intranasal administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>300&#8239;micrograms, blood to be sampled after 1 hour for fibrinolytic activity, one 150&#8239;microgram spray to be administered into each nostril.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection or by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>300&#8239;nanograms/kg for 1 dose, blood to be sampled after 20 minutes for fibrinolytic activity.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Lumbar-puncture-associated headache</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection or by subcutaneous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>(consult product literature).</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64226\" outputclass=\"unlicensedUse\" rev=\"1.12\" parent=\"/drugs/desmopressin\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Consult product literature for individual preparations.</p>\n<p>Not licensed for assessment of antidiuretic hormone secretion.</p>\n<p>Oral use of <i>DDAVP</i> intravenous injection is not licensed.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64850\" outputclass=\"contraindications\" rev=\"1.7\" parent=\"/drugs/desmopressin\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Cardiac insufficiency</ph>; <ph outputclass=\"contraindication\">conditions treated with diuretics</ph>; <ph outputclass=\"contraindication\">polydipsia in alcohol dependence</ph>; <ph outputclass=\"contraindication\">psychogenic polydipsia</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64884\" outputclass=\"cautions\" rev=\"1.15\" parent=\"/drugs/desmopressin\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<title>General cautions:</title>\n<p>\n<ph outputclass=\"caution\">Asthma</ph>; <ph outputclass=\"caution\">avoid fluid overload</ph>; <ph outputclass=\"caution\">cardiovascular disease (not indicated for nocturnal enuresis or noctuira)</ph>; <ph outputclass=\"caution\">conditions which might be aggravated by water retention</ph>; <ph outputclass=\"caution\">cystic fibrosis</ph>; <ph outputclass=\"caution\">elderly (avoid for nocturnal enuresis and nocturia in those over 65 years)</ph> (in adults); <ph outputclass=\"caution\">epilepsy</ph>; <ph outputclass=\"caution\">heart failure</ph>; <ph outputclass=\"caution\">hypertension (not indicated for nocturnal enuresis or noctuira)</ph>; <ph outputclass=\"caution\">migraine</ph>; <ph outputclass=\"caution\">nocturia&#8212;limit fluid intake to minimum from 1 hour before dose until 8 hours afterwards</ph>; <ph outputclass=\"caution\">nocturnal enuresis&#8212;limit fluid intake to minimum from 1 hour before dose until 8 hours afterwards</ph>\n</p>\n<sectiondiv outputclass=\"additionalCautions\">\n<p outputclass=\"title\">Specific cautions:</p>\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With intranasal use</p>\n<p>\n<ph outputclass=\"caution\">should not be given intranasally for nocturnal enuresis due to an increased incidence of side-effects</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64347\" outputclass=\"interactions\" rev=\"1.6\" parent=\"/drugs/desmopressin\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (desmopressin).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64275\" outputclass=\"sideEffects\" rev=\"1.10\" parent=\"/drugs/desmopressin\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<title>General side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Allergic reactions</ph>; <ph outputclass=\"sideEffect\">emotional disturbance in children</ph>; <ph outputclass=\"sideEffect\">epistaxis</ph>; <ph outputclass=\"sideEffect\">fluid retention</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hyponatraemia (in more serious cases with convulsions) on administration without restricting fluid intake</ph>; <ph outputclass=\"sideEffect\">nasal congestion</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">stomach pain</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"specificSideEffects\">\n<title>Specific side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intranasal use</p>\n<p>\n<ph outputclass=\"sideEffect\">rhinitis</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Hyponatraemic convulsions</p>\n<p> The risk of hyponatraemic convulsions can be minimised by keeping to the recommended starting doses and by avoiding concomitant use of drugs which increase secretion of vasopressin (e.g. tricyclic antidepressants).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64336\" outputclass=\"pregnancy\" parent=\"/drugs/desmopressin\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Small oxytocic effect in third trimester; increased risk of pre-eclampsia.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64898\" outputclass=\"breastFeeding\" parent=\"/drugs/desmopressin\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Amount too small to be harmful.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64303\" outputclass=\"renalImpairment\" parent=\"/drugs/desmopressin\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution; antidiuretic effect may be reduced.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64205\" outputclass=\"monitoringRequirements\" parent=\"/drugs/desmopressin\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>In <i>nocturia</i>, periodic blood pressure and weight checks are needed to monitor for fluid overload.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64927\" outputclass=\"directionsForAdministration\" rev=\"1.18\" parent=\"/drugs/desmopressin\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>\n<i>DDVAP</i>\n<tm tmtype=\"reg\"/> and <i>Desmotabs</i>\n<tm tmtype=\"reg\"/> tablets may be crushed.</p>\n</sectiondiv>\n<sectiondiv>\n<p>\n<i>DDAVP</i>\n<tm tmtype=\"reg\"/> intranasal solution may be diluted with Sodium Chloride 0.9% to a concentration of 10&#8239;micrograms/mL.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Higher doses of <i>DDAVP</i>\n<tm tmtype=\"reg\"/> by <i>intravenous infusion</i>, used in mild to moderate haemophilia and von Willebrand&#8217;s disease, may be diluted with 30&#8211;50&#8239;mL Sodium Chloride 0.9% intravenous infusion.</p>\n</sectiondiv>\n<sectiondiv>\n<p>\n<i>DDAVP</i>\n<tm tmtype=\"reg\"/> injection may be administered orally.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>For <i>intravenous infusion</i> (<i>Octim</i>\n<tm tmtype=\"reg\"/>), dilute with 50&#8239;mL of Sodium Chloride 0.9% and give over 20 minutes.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in adults</p>\n<p>For <i>intravenous infusion</i> (<i>DDVAP</i>\n<tm tmtype=\"reg\"/>, <i>Octim</i>\n<tm tmtype=\"reg\"/>), give intermittently in Sodium chloride 0.9%; dilute with 50&#8239;mL and give over 20 minutes.</p>\n</sectiondiv>\n<sectiondiv>\n<p>Desmopressin oral lyophilisates are for sublingual administration.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP59239\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.20\" parent=\"/drugs/desmopressin\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Oral, intranasal, intravenous, subcutaneous and intramuscular doses are expressed as desmopressin acetate; sublingual doses are expressed as desmopressin base.</p>\n<p>Children requiring an intranasal dose of less than 10&#8239;micrograms should be given <i>DDAVP</i>\n<tm tmtype=\"reg\"/> intranasal solution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64319\" outputclass=\"patientAndCarerAdvice\" rev=\"1.24\" parent=\"/drugs/desmopressin\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Desmopressin for bedwetting</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/desmopressin-bedwetting-0\">www.medicinesforchildren.org.uk/desmopressin-bedwetting-0</xref>\n</p>\n</sectiondiv>\n</section>\r\n<section outputclass=\"generalPatientAdvice\">\r\n<sectiondiv>\r\n<p outputclass=\"title\">Hyponatraemic convulsions</p>\r\n<p>Patients being treated for primary nocturnal enuresis should be warned to avoid fluid overload (including during swimming) and to stop taking desmopressin during an episode of vomiting or diarrhoea (until fluid balance normal).</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP4622-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/desmopressin\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension, spray, oral solution, capsule, nasal drops</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75072\" title=\"Tablet\" namespace=\"/drugs/desmopressin/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75123\" title=\"Oral solution\" namespace=\"/drugs/desmopressin/oral-solution\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75102\" title=\"Oral lyophilisate\" namespace=\"/drugs/desmopressin/oral-lyophilisate\">Oral lyophilisate</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75091\" title=\"Solution for injection\" namespace=\"/drugs/desmopressin/solution-for-injection\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75097\" title=\"Spray\" namespace=\"/drugs/desmopressin/spray\">Spray</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75117\" title=\"Nasal drops\" namespace=\"/drugs/desmopressin/nasal-drops\">Nasal drops</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78133\" namespace=\"/treatment-summaries/antifibrinolytic-drugs-and-haemostatics\" title=\"Antifibrinolytic drugs and haemostatics\" count=\"1\" rel=\"backlink\">Antifibrinolytic drugs and haemostatics</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78308\" namespace=\"/treatment-summaries/posterior-pituitary-hormones-and-antagonists\" title=\"Posterior pituitary hormones and antagonists\" count=\"5\" rel=\"backlink\">Posterior pituitary hormones and antagonists</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78573\" namespace=\"/treatment-summaries/urinary-frequency-enuresis-and-incontinence\" title=\"Urinary frequency, enuresis and incontinence\" count=\"7\" rel=\"backlink\">Urinary frequency, enuresis and incontinence</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_795\" namespace=\"/interactions/list-of-drug-interactions/desmopressin\" title=\"Desmopressin\" count=\"1\" rel=\"link\">Desmopressin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75072\" namespace=\"/drugs/desmopressin/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75123\" namespace=\"/drugs/desmopressin/oral-solution\" title=\"Oral solution\" count=\"1\" rel=\"link\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75102\" namespace=\"/drugs/desmopressin/oral-lyophilisate\" title=\"Oral lyophilisate\" count=\"1\" rel=\"link\">Oral lyophilisate</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75091\" namespace=\"/drugs/desmopressin/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75097\" namespace=\"/drugs/desmopressin/spray\" title=\"Spray\" count=\"1\" rel=\"link\">Spray</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75117\" namespace=\"/drugs/desmopressin/nasal-drops\" title=\"Nasal drops\" count=\"1\" rel=\"link\">Nasal drops</xref>\n</links>\n</topic>",
    "id": "PHP4622",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/desmopressin",
    "basename": "desmopressin",
    "title": "DESMOPRESSIN",
    "interactants": [
        {
            "id": "bnf_int_795",
            "label": "Desmopressin"
        }
    ],
    "vtmid": "73454001",
    "drugClassification": [
        "Vasopressin and analogues"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Desmopressin is an analogue of vasopressin.",
                "html": "<p>Desmopressin is an analogue of vasopressin.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Diabetes insipidus, treatment",
                        "html": "Diabetes insipidus, treatment"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection or intravenous injection or intramuscular injection"
                    ],
                    "textContent": "By subcutaneous injection or by intravenous injection or by intramuscular injection",
                    "html": "By subcutaneous injection or by intravenous injection or by intramuscular injection"
                },
                "child": [
                    {
                        "textContent": "Initially 10 micrograms 2&#8211;3 times a day, adjusted according to response; usual dose 30&#8211;150 micrograms daily.",
                        "html": "<p>Initially 10&#8239;micrograms 2&#8211;3 times a day, adjusted according to response; usual dose 30&#8211;150&#8239;micrograms daily.</p>",
                        "ageGroup": "1 month&#8211;1 year"
                    },
                    {
                        "textContent": "Initially 50 micrograms 2&#8211;3 times a day, adjusted according to response; usual dose 100&#8211;800 micrograms daily.",
                        "html": "<p>Initially 50&#8239;micrograms 2&#8211;3 times a day, adjusted according to response; usual dose 100&#8211;800&#8239;micrograms daily.</p>",
                        "ageGroup": "2&#8211;11 years"
                    },
                    {
                        "textContent": "Initially 100 micrograms 2&#8211;3 times a day, adjusted according to response; usual dose 0.2&#8211;1.2 mg daily.",
                        "html": "<p>Initially 100&#8239;micrograms 2&#8211;3 times a day, adjusted according to response; usual dose 0.2&#8211;1.2&#8239;mg daily.</p>",
                        "ageGroup": "12&#8211;17 years"
                    },
                    {
                        "textContent": "Initially 60 micrograms 3 times a day, adjusted according to response; usual dose 40&#8211;240 micrograms 3 times a day.",
                        "html": "<p>Initially 60&#8239;micrograms 3 times a day, adjusted according to response; usual dose 40&#8211;240&#8239;micrograms 3 times a day.</p>",
                        "ageGroup": "2&#8211;17 years"
                    },
                    {
                        "textContent": "Initially 2.5&#8211;5 micrograms 1&#8211;2 times a day, adjusted according to response.",
                        "html": "<p>Initially 2.5&#8211;5&#8239;micrograms 1&#8211;2 times a day, adjusted according to response.</p>",
                        "ageGroup": "1 month&#8211;1 year"
                    },
                    {
                        "textContent": "Initially 5&#8211;20 micrograms 1&#8211;2 times a day, adjusted according to response.",
                        "html": "<p>Initially 5&#8211;20&#8239;micrograms 1&#8211;2 times a day, adjusted according to response.</p>",
                        "ageGroup": "2&#8211;11 years"
                    },
                    {
                        "textContent": "Initially 10&#8211;20 micrograms 1&#8211;2 times a day, adjusted according to response.",
                        "html": "<p>Initially 10&#8211;20&#8239;micrograms 1&#8211;2 times a day, adjusted according to response.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 100 micrograms 3 times a day; maintenance 100&#8211;200 micrograms 3 times a day; usual dose 0.2&#8211;1.2 mg daily.",
                        "html": "<p>Initially 100&#8239;micrograms 3 times a day; maintenance 100&#8211;200&#8239;micrograms 3 times a day; usual dose 0.2&#8211;1.2&#8239;mg daily.</p>"
                    },
                    {
                        "textContent": "Initially 60 micrograms 3 times a day, adjusted according to response; usual dose 40&#8211;240 micrograms 3 times a day.",
                        "html": "<p>Initially 60&#8239;micrograms 3 times a day, adjusted according to response; usual dose 40&#8211;240&#8239;micrograms 3 times a day.</p>"
                    },
                    {
                        "textContent": "10&#8211;40 micrograms daily in 1&#8211;2 divided doses.",
                        "html": "<p>10&#8211;40&#8239;micrograms daily in 1&#8211;2 divided doses.</p>"
                    },
                    {
                        "textContent": "1&#8211;4 micrograms daily.",
                        "html": "<p>1&#8211;4&#8239;micrograms daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Primary nocturnal enuresis",
                        "html": "Primary nocturnal enuresis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "sublingual administration"
                    ],
                    "textContent": "By sublingual administration",
                    "html": "By sublingual administration"
                },
                "child": [
                    {
                        "textContent": "200 micrograms once daily, only increased to 400 micrograms if lower dose not effective; withdraw for at least 1 week for reassessment after 3 months, dose to be taken at bedtime, limit fluid intake from 1 hour before to 8 hours after administration.",
                        "html": "<p>200&#8239;micrograms once daily, only increased to 400&#8239;micrograms if lower dose not effective; withdraw for at least 1 week for reassessment after 3 months, dose to be taken at bedtime, limit fluid intake from 1 hour before to 8 hours after administration.</p>",
                        "ageGroup": "5&#8211;17 years"
                    },
                    {
                        "textContent": "120 micrograms once daily, increased if necessary to 240 micrograms once daily, dose to be taken at bedtime, limit fluid intake from 1 hour before to 8 hours after administration, dose to be increased only if lower dose not effective, reassess after 3 months by withdrawing treatment for at least 1 week.",
                        "html": "<p>120&#8239;micrograms once daily, increased if necessary to 240&#8239;micrograms once daily, dose to be taken at bedtime, limit fluid intake from 1 hour before to 8 hours after administration, dose to be increased only if lower dose not effective, reassess after 3 months by withdrawing treatment for at least 1 week.</p>",
                        "ageGroup": "5&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "200 micrograms once daily, only increased to 400 micrograms if lower dose not effective; withdraw for at least 1 week for reassessment after 3 months, dose to be taken at bedtime, limit fluid intake from 1 hour before to 8 hours after administration.",
                        "html": "<p>200&#8239;micrograms once daily, only increased to 400&#8239;micrograms if lower dose not effective; withdraw for at least 1 week for reassessment after 3 months, dose to be taken at bedtime, limit fluid intake from 1 hour before to 8 hours after administration.</p>",
                        "ageGroup": "18&#8211;65 years"
                    },
                    {
                        "textContent": "120 micrograms once daily, increased if necessary to 240 micrograms once daily, dose to be taken at bedtime, limit fluid intake from 1 hour before to 8 hours after administration, dose to be increased only if lower dose not effective, reassess after 3 months by withdrawing treatment for at least 1 week.",
                        "html": "<p>120&#8239;micrograms once daily, increased if necessary to 240&#8239;micrograms once daily, dose to be taken at bedtime, limit fluid intake from 1 hour before to 8 hours after administration, dose to be increased only if lower dose not effective, reassess after 3 months by withdrawing treatment for at least 1 week.</p>",
                        "ageGroup": "18&#8211;65 years"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Postoperative polyuria or polydipsia",
                        "html": "Postoperative polyuria or polydipsia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Dose to be adjusted according to urine osmolality.",
                        "html": "<p>Dose to be adjusted according to urine osmolality.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Polyuria or polydipsia after hypophysectomy",
                        "html": "Polyuria or polydipsia after hypophysectomy"
                    }
                ],
                "specificity": {
                    "routes": [
                        "sublingual administration"
                    ],
                    "textContent": "By sublingual administration",
                    "html": "By sublingual administration"
                },
                "adult": [
                    {
                        "textContent": "Dose to be adjusted according to urine osmolality.",
                        "html": "<p>Dose to be adjusted according to urine osmolality.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Diabetes insipidus, diagnosis (water deprivation test)",
                        "html": "Diabetes insipidus, diagnosis (water deprivation test)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection or subcutaneous injection"
                    ],
                    "textContent": "By intramuscular injection or by subcutaneous injection",
                    "html": "By intramuscular injection or by subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "20 micrograms, limit fluid intake to 500 mL from 1 hour before to 8 hours after administration.",
                        "html": "<p>20&#8239;micrograms, limit fluid intake to 500&#8239;mL from 1 hour before to 8 hours after administration.</p>"
                    },
                    {
                        "textContent": "2 micrograms for 1 dose, limit fluid intake to 500 mL from 1 hour before to 8 hours after administration.",
                        "html": "<p>2&#8239;micrograms for 1 dose, limit fluid intake to 500&#8239;mL from 1 hour before to 8 hours after administration.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Nocturia associated with multiple sclerosis (when other treatments have failed)",
                        "html": "Nocturia associated with multiple sclerosis (when other treatments have failed)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intranasal administration"
                    ],
                    "textContent": "By intranasal administration",
                    "html": "By intranasal administration"
                },
                "adult": [
                    {
                        "textContent": "10&#8211;20 micrograms once daily, to be taken at bedtime, dose not to be repeated within 24 hours, limit fluid intake from 1 hour before to 8 hours after administration.",
                        "html": "<p>10&#8211;20&#8239;micrograms once daily, to be taken at bedtime, dose not to be repeated within 24 hours, limit fluid intake from 1 hour before to 8 hours after administration.</p>",
                        "ageGroup": "18&#8211;65 years"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Renal function testing",
                        "html": "Renal function testing"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection or intramuscular injection"
                    ],
                    "textContent": "By subcutaneous injection or by intramuscular injection",
                    "html": "By subcutaneous injection or by intramuscular injection"
                },
                "adult": [
                    {
                        "textContent": "40 micrograms, empty bladder at time of administration and limit fluid intake to 500 mL from 1 hour before until 8 hours after administration to avoid fluid overload.",
                        "html": "<p>40&#8239;micrograms, empty bladder at time of administration and limit fluid intake to 500&#8239;mL from 1 hour before until 8 hours after administration to avoid fluid overload.</p>"
                    },
                    {
                        "textContent": "2 micrograms, empty bladder at time of administration and restrict fluid intake to 500 mL from 1 hour before until 8 hours after administration to avoid fluid overload.",
                        "html": "<p>2&#8239;micrograms, empty bladder at time of administration and restrict fluid intake to 500&#8239;mL from 1 hour before until 8 hours after administration to avoid fluid overload.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Mild to moderate haemophilia and von Willebrand&#8217;s disease",
                        "html": "Mild to moderate haemophilia and von Willebrand&#8217;s disease"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion or subcutaneous injection"
                    ],
                    "textContent": "By intravenous infusion or by subcutaneous injection",
                    "html": "By intravenous infusion or by subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "300 micrograms every 12 hours if required, one 150 microgram spray into each nostril, 30 minutes before surgery or when bleeding, dose may alternatively be repeated at intervals of at least 3 days, if self-administered.",
                        "html": "<p>300&#8239;micrograms every 12&#8239;hours if required, one 150&#8239;microgram spray into each nostril, 30 minutes before surgery or when bleeding, dose may alternatively be repeated at intervals of at least 3&#8239;days, if self-administered.</p>"
                    },
                    {
                        "textContent": "300 nanograms/kg for 1 dose, to be administered immediately before surgery or after trauma; may be repeated at intervals of 12 hours if no tachycardia.",
                        "html": "<p>300&#8239;nanograms/kg for 1 dose, to be administered immediately before surgery or after trauma; may be repeated at intervals of 12 hours if no tachycardia.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Fibrinolytic response testing",
                        "html": "Fibrinolytic response testing"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous injection or intravenous injection"
                    ],
                    "textContent": "By subcutaneous injection or by intravenous injection",
                    "html": "By subcutaneous injection or by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "300 micrograms, blood to be sampled after 1 hour for fibrinolytic activity, one 150 microgram spray to be administered into each nostril.",
                        "html": "<p>300&#8239;micrograms, blood to be sampled after 1 hour for fibrinolytic activity, one 150&#8239;microgram spray to be administered into each nostril.</p>"
                    },
                    {
                        "textContent": "300 nanograms/kg for 1 dose, blood to be sampled after 20 minutes for fibrinolytic activity.",
                        "html": "<p>300&#8239;nanograms/kg for 1 dose, blood to be sampled after 20 minutes for fibrinolytic activity.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Lumbar-puncture-associated headache",
                        "html": "Lumbar-puncture-associated headache"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection or subcutaneous injection"
                    ],
                    "textContent": "By intramuscular injection or by subcutaneous injection",
                    "html": "By intramuscular injection or by subcutaneous injection"
                },
                "adult": [
                    {
                        "textContent": "(consult product literature).",
                        "html": "<p>(consult product literature).</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Consult product literature for individual preparations.\n\nNot licensed for assessment of antidiuretic hormone secretion.\n\nOral use of DDAVP intravenous injection is not licensed.",
                "html": "<p>Consult product literature for individual preparations.</p><p>Not licensed for assessment of antidiuretic hormone secretion.</p><p>Oral use of <i>DDAVP</i> intravenous injection is not licensed.</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Cardiac insufficiency",
                "html": "Cardiac insufficiency"
            },
            {
                "type": "contraindications",
                "textContent": "conditions treated with diuretics",
                "html": "conditions treated with diuretics"
            },
            {
                "type": "contraindications",
                "textContent": "polydipsia in alcohol dependence",
                "html": "polydipsia in alcohol dependence"
            },
            {
                "type": "contraindications",
                "textContent": "psychogenic polydipsia",
                "html": "psychogenic polydipsia"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Asthma",
                "html": "Asthma"
            },
            {
                "type": "cautions",
                "textContent": "avoid fluid overload",
                "html": "avoid fluid overload"
            },
            {
                "type": "cautions",
                "textContent": "cardiovascular disease (not indicated for nocturnal enuresis or noctuira)",
                "html": "cardiovascular disease (not indicated for nocturnal enuresis or noctuira)"
            },
            {
                "type": "cautions",
                "textContent": "conditions which might be aggravated by water retention",
                "html": "conditions which might be aggravated by water retention"
            },
            {
                "type": "cautions",
                "textContent": "cystic fibrosis",
                "html": "cystic fibrosis"
            },
            {
                "type": "cautions",
                "textContent": "elderly (avoid for nocturnal enuresis and nocturia in those over 65 years) in adults",
                "html": "elderly (avoid for nocturnal enuresis and nocturia in those over 65 years) in adults",
                "specificity": {
                    "patientType": "adults"
                }
            },
            {
                "type": "cautions",
                "textContent": "epilepsy",
                "html": "epilepsy"
            },
            {
                "type": "cautions",
                "textContent": "heart failure",
                "html": "heart failure"
            },
            {
                "type": "cautions",
                "textContent": "hypertension (not indicated for nocturnal enuresis or noctuira)",
                "html": "hypertension (not indicated for nocturnal enuresis or noctuira)"
            },
            {
                "type": "cautions",
                "textContent": "migraine",
                "html": "migraine"
            },
            {
                "type": "cautions",
                "textContent": "nocturia&#8212;limit fluid intake to minimum from 1 hour before dose until 8 hours afterwards",
                "html": "nocturia&#8212;limit fluid intake to minimum from 1 hour before dose until 8 hours afterwards"
            },
            {
                "type": "cautions",
                "textContent": "nocturnal enuresis&#8212;limit fluid intake to minimum from 1 hour before dose until 8 hours afterwards",
                "html": "nocturnal enuresis&#8212;limit fluid intake to minimum from 1 hour before dose until 8 hours afterwards"
            }
        ],
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "should not be given intranasally for nocturnal enuresis due to an increased incidence of side-effects",
                "html": "should not be given intranasally for nocturnal enuresis due to an increased incidence of side-effects",
                "specificity": {
                    "textContent": "With intranasal use",
                    "html": "With intranasal use",
                    "routes": [
                        "intranasal"
                    ]
                }
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (desmopressin).",
                "html": "<p>Appendix 1 (desmopressin).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Allergic reactions",
                        "html": "Allergic reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "emotional disturbance in children",
                        "html": "emotional disturbance in children",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "epistaxis",
                        "html": "epistaxis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "fluid retention",
                        "html": "fluid retention",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hyponatraemia (in more serious cases with convulsions) on administration without restricting fluid intake",
                        "html": "hyponatraemia (in more serious cases with convulsions) on administration without restricting fluid intake",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nasal congestion",
                        "html": "nasal congestion",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "stomach pain",
                        "html": "stomach pain",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "specific": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "rhinitis",
                        "html": "rhinitis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intranasal use",
                            "html": "With intranasal use",
                            "routes": [
                                "intranasal"
                            ]
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Hyponatraemic convulsions",
                "textContent": "The risk of hyponatraemic convulsions can be minimised by keeping to the recommended starting doses and by avoiding concomitant use of drugs which increase secretion of vasopressin (e.g. tricyclic antidepressants).",
                "html": "<p> The risk of hyponatraemic convulsions can be minimised by keeping to the recommended starting doses and by avoiding concomitant use of drugs which increase secretion of vasopressin (e.g. tricyclic antidepressants).</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Small oxytocic effect in third trimester; increased risk of pre-eclampsia.",
                "html": "<p>Small oxytocic effect in third trimester; increased risk of pre-eclampsia.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Amount too small to be harmful.",
                "html": "<p>Amount too small to be harmful.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution; antidiuretic effect may be reduced.",
                "html": "<p>Use with caution; antidiuretic effect may be reduced.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "In nocturia, periodic blood pressure and weight checks are needed to monitor for fluid overload.",
                "html": "<p>In <i>nocturia</i>, periodic blood pressure and weight checks are needed to monitor for fluid overload.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "DDVAP and Desmotabs tablets may be crushed.",
                "html": "<p>\n<i>DDVAP</i>\n<tm tmtype=\"reg\"/> and <i>Desmotabs</i>\n<tm tmtype=\"reg\"/> tablets may be crushed.</p>"
            },
            {
                "type": "directionsForAdministration",
                "textContent": "DDAVP intranasal solution may be diluted with Sodium Chloride 0.9% to a concentration of 10 micrograms/mL.",
                "html": "<p>\n<i>DDAVP</i>\n<tm tmtype=\"reg\"/> intranasal solution may be diluted with Sodium Chloride 0.9% to a concentration of 10&#8239;micrograms/mL.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Higher doses of DDAVP by intravenous infusion, used in mild to moderate haemophilia and von Willebrand&#8217;s disease, may be diluted with 30&#8211;50 mL Sodium Chloride 0.9% intravenous infusion.",
                "html": "<p>Higher doses of <i>DDAVP</i>\n<tm tmtype=\"reg\"/> by <i>intravenous infusion</i>, used in mild to moderate haemophilia and von Willebrand&#8217;s disease, may be diluted with 30&#8211;50&#8239;mL Sodium Chloride 0.9% intravenous infusion.</p>"
            },
            {
                "type": "directionsForAdministration",
                "textContent": "DDAVP injection may be administered orally.",
                "html": "<p>\n<i>DDAVP</i>\n<tm tmtype=\"reg\"/> injection may be administered orally.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "For intravenous infusion (Octim ), dilute with 50 mL of Sodium Chloride 0.9% and give over 20 minutes.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Octim</i>\n<tm tmtype=\"reg\"/>), dilute with 50&#8239;mL of Sodium Chloride 0.9% and give over 20 minutes.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in adults",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (DDVAP , Octim ), give intermittently in Sodium chloride 0.9%; dilute with 50 mL and give over 20 minutes.",
                "html": "<p>For <i>intravenous infusion</i> (<i>DDVAP</i>\n<tm tmtype=\"reg\"/>, <i>Octim</i>\n<tm tmtype=\"reg\"/>), give intermittently in Sodium chloride 0.9%; dilute with 50&#8239;mL and give over 20 minutes.</p>"
            },
            {
                "type": "directionsForAdministration",
                "textContent": "Desmopressin oral lyophilisates are for sublingual administration.",
                "html": "<p>Desmopressin oral lyophilisates are for sublingual administration.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Oral, intranasal, intravenous, subcutaneous and intramuscular doses are expressed as desmopressin acetate; sublingual doses are expressed as desmopressin base.\n\nChildren requiring an intranasal dose of less than 10 micrograms should be given DDAVP intranasal solution.",
                "html": "<p>Oral, intranasal, intravenous, subcutaneous and intramuscular doses are expressed as desmopressin acetate; sublingual doses are expressed as desmopressin base.</p><p>Children requiring an intranasal dose of less than 10&#8239;micrograms should be given <i>DDAVP</i>\n<tm tmtype=\"reg\"/> intranasal solution.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/desmopressin-bedwetting-0",
                        "label": "www.medicinesforchildren.org.uk/desmopressin-bedwetting-0"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Desmopressin for bedwetting",
                "textContent": "www.medicinesforchildren.org.uk/desmopressin-bedwetting-0",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/desmopressin-bedwetting-0\">www.medicinesforchildren.org.uk/desmopressin-bedwetting-0</xref>\n</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "title": "Hyponatraemic convulsions",
                "textContent": "Patients being treated for primary nocturnal enuresis should be warned to avoid fluid overload (including during swimming) and to stop taking desmopressin during an episode of vomiting or diarrhoea (until fluid balance normal).",
                "html": "<p>Patients being treated for primary nocturnal enuresis should be warned to avoid fluid overload (including during swimming) and to stop taking desmopressin during an episode of vomiting or diarrhoea (until fluid balance normal).</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension",
                "spray",
                "oral solution",
                "capsule",
                "nasal drops"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75072",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75123",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75102",
                "label": "Oral lyophilisate",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75091",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75097",
                "label": "Spray",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75117",
                "label": "Nasal drops",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78133",
                "label": "Antifibrinolytic drugs and haemostatics",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78308",
                "label": "Posterior pituitary hormones and antagonists",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78573",
                "label": "Urinary frequency, enuresis and incontinence",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_795",
                "label": "Desmopressin",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75072",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75123",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75102",
                "label": "Oral lyophilisate",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75091",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75097",
                "label": "Spray",
                "type": "medicinalForm"
            },
            {
                "id": "PHP75117",
                "label": "Nasal drops",
                "type": "medicinalForm"
            }
        ]
    }
}